Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 12
Review
SGLT-2 inhibitors as promising therapeutics for non-alcoholic fatty liver disease: pathophysiology, clinical outcomes, and future directions
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
11,554 | Dovepress* | 9,170+ | 1,898 | 11,068 | |
PubMed Central* | 2,384 | 707 | 3,091 | ||
Totals | 11,554 | 2,605 | 14,159 | ||
*Since 3 July 2019 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 1 |
View citations on PubMed Central and Google Scholar